Recruiting

Observational Study

Sponsor:

Health Sciences North Research Institute

Code:

NCT04504474

Conditions

ADHD

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The study is an investigation to determine co-morbid symptoms between adult major depressive disorder (MDD) and adult attention-deficit hyperactivity disorder (ADHD) using a novel statistical technique called network analysis.

Conditions

ADHD

Study ID

NCT04504474

Start date

Jun 21, 2018

Status verified date

Aug, 2020

Completion date

Sep 8, 2021

Anticipated

Primary completion date

Aug 8, 2021

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • participants have a diagnosis of MDD or ADHD or both
  • participants are competent to consent to the study

Study Design

Enrollment

500 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Co-morbidity [ Time Frame: September 8, 2021 ]
  • Network reliability [ Time Frame: September 8, 2021 ]
  • Central symptoms [ Time Frame: September 8, 2021 ]

Central Contacts and Locations

Central contacts

Kuppuswami Shivakumar, M.D.

705-523-7100kshivakumar@hsnsudbury.ca

Locations

Kirkwood Site - Health Sciences North

Recruiting

Sudbury, Ontario, Canada, P3E 1X3

Contacts

Kevin Saroka, Ph.D.

705-523-7100ksaroka@hsnsudbury.ca

More Information

Sponsor

Health Sciences North Research Institute

Last update posted

Aug 7, 2020

Last verified

Aug, 2020

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Health Sciences North Research Institute on 2020-08-07.